PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

”China would also need its own registration studies”Yeah that’s...

  1. 3,772 Posts.
    lightbulb Created with Sketch. 1549
    ”China would also need its own registration studies”

    Yeah that’s called copy it, then say “what ya talking about? It’s different.” Or they just copy and let it circulate on the black market.

    And before someone says they won’t be able to copy it, they’ll find something close enough.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.